BioSpace News Archive

Dante Genomics , a global leader in genomics and precision medicine, announced that the Company will be participating in The Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum. Andrea Riposati, CEO of Dante Genomics, will present at the conference on Thursday, November 17, 2022 at 9:30 AM Eastern Time.

Ainos, Inc. today announced its unaudited financial results for the third quarter ended September 30, 2022.

Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Monday, November 14, 2022 to report its third quarter 2022 financial results and provide a corporate update.

Repare Therapeutics Inc. today announced that members of its senior management team will participate at two investor conferences in November.

Better Therapeutics, Inc today announced it will release its third quarter 2022 financial results after the market closes on Monday, November 14, 2022.

bluebird bio, Inc. today reported financial results and business highlights for the third quarter ended September 30, 2022 and shared recent operational progress.

Selecta Biosciences, Inc. today announced that Company’s Management will participate in a presentation and one-on-one investor meetings at the Guggenheim Healthcare Talks | 4th Annual Immunology & Neurology Day, to be held in-person in New York, NY from November 14-15, 2022.

Spero Therapeutics, Inc. today announced that it will host a conference call and live audio webcast on Monday, November 14, 2022 at 4:30 p.m. ET to report its third quarter 2022 financial results.

Surface Oncology today announced the presentation of two posters at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting in Boston.

Lyell Immunopharma, Inc. is presenting preclinical data at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on its product candidates and new genetic and epigenetic reprogramming technologies.